The global In-vitro fertilization microscope market is envisioned to garner $250.4 million by 2031, growing from $105.4 million in 2021 at a CAGR of 9.4% from 2022 to 2031.
IVF has become one of the most popular forms of assisted reproductive technology for infertility and gestational surrogacy. During the IVF procedure, an egg is in vitro combined with sperm. People who are unable to conceive naturally may be able to use this method to have a baby. The rise in cases of infertility worldwide is providing a significant impetus to the growth of the in-vitro fertilization and in-vitro fertilization microscope market. According to the World Health Organization (WHO), approximately 48 million couples and 186 million individuals worldwide suffer from infertility. During the forecast period, this is expected to continue to drive demand for in vitro fertilization, which is further anticipated to drive the demand for in-vitro fertilization microscope market.
Despite positive growth projections, certain factors are impeding the growth of the IVF market. Some of these factors include the high cost of IVF treatments, a lack of proper reimbursement policies, and declining IVF treatment success rates, hence, hindering the In-vitro fertilization microscope market growth.
The rise in prevalence of infertility among men and women is expected to drive growth in the market for IVF microscopes. According to World Health Organization data, approximately 186 million people and approximately 48 million couples worldwide suffer from infertility. In 2020, approximately 0.29 million IVF cycles were initiated in the U.S. according to the U.S. Society of Assisted Reproductive Technology (SART). Furthermore, rise in awareness & advancements in IVF technology, an increase in the number of delayed pregnancies, and surge in infertility among couples are the factors driving the IVF microscope market. Multiply, an IVF-tech firm, for example, unveiled an AI-based platform designed to replace traditional operations in IVF facilities in December 2021.
The COVID-19 pandemic brought several uncertainties leading to severe economic losses as various businesses across the world were on a standstill. Moreover, there were import-export restrictions laid down on major microscope manufacturing companies in countries such as the U.S. and China, which imposed significant challenges on the market. Owing to the sudden shutdown of activities to prevent the spread of infection during the pandemic, there was a decrease in the manufacturing and supply of all types of medical devices, including microscopes.
The key players profiled in this report include Linkam Scientific Instruments, Olympus Corporation, Leica Microsystems, Meiji Techno, Zeiss, Euromex Microscopen B.V., Labomed Europe B.V., Nikon Corporation, Narishige Group, Eppendorf AG, and Hamilton Thorne Ltd.
IVF has become one of the most popular forms of assisted reproductive technology for infertility and gestational surrogacy. During the IVF procedure, an egg is in vitro combined with sperm. People who are unable to conceive naturally may be able to use this method to have a baby. The rise in cases of infertility worldwide is providing a significant impetus to the growth of the in-vitro fertilization and in-vitro fertilization microscope market. According to the World Health Organization (WHO), approximately 48 million couples and 186 million individuals worldwide suffer from infertility. During the forecast period, this is expected to continue to drive demand for in vitro fertilization, which is further anticipated to drive the demand for in-vitro fertilization microscope market.
Despite positive growth projections, certain factors are impeding the growth of the IVF market. Some of these factors include the high cost of IVF treatments, a lack of proper reimbursement policies, and declining IVF treatment success rates, hence, hindering the In-vitro fertilization microscope market growth.
The rise in prevalence of infertility among men and women is expected to drive growth in the market for IVF microscopes. According to World Health Organization data, approximately 186 million people and approximately 48 million couples worldwide suffer from infertility. In 2020, approximately 0.29 million IVF cycles were initiated in the U.S. according to the U.S. Society of Assisted Reproductive Technology (SART). Furthermore, rise in awareness & advancements in IVF technology, an increase in the number of delayed pregnancies, and surge in infertility among couples are the factors driving the IVF microscope market. Multiply, an IVF-tech firm, for example, unveiled an AI-based platform designed to replace traditional operations in IVF facilities in December 2021.
The COVID-19 pandemic brought several uncertainties leading to severe economic losses as various businesses across the world were on a standstill. Moreover, there were import-export restrictions laid down on major microscope manufacturing companies in countries such as the U.S. and China, which imposed significant challenges on the market. Owing to the sudden shutdown of activities to prevent the spread of infection during the pandemic, there was a decrease in the manufacturing and supply of all types of medical devices, including microscopes.
The key players profiled in this report include Linkam Scientific Instruments, Olympus Corporation, Leica Microsystems, Meiji Techno, Zeiss, Euromex Microscopen B.V., Labomed Europe B.V., Nikon Corporation, Narishige Group, Eppendorf AG, and Hamilton Thorne Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the in-vitro fertilization microscopes market analysis from 2021 to 2031 to identify the prevailing in-vitro fertilization microscopes market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the in-vitro fertilization microscopes market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global in-vitro fertilization microscopes market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Upright Microscopes
- Inverted Microscopes
- Stereo Microscopes
- Embryo Microscope
By End User
- Clinical
- Academic Research
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of LAMEA
Key Market Players
- LINKAM SCIENTIFIC INSTRUMENTS
- Olympus Corporation
- Leica Microsystems
- Meiji Techno.
- ZEISS International
- Euromex Microscopen B.V.
- Labomed Europe B.V.
- Nikon Corporation
- NARISHIGE Group.
- hamilton thorne, inc.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: IN-VITRO FERTILIZATION MICROSCOPES MARKET, BY TYPE
CHAPTER 5: IN-VITRO FERTILIZATION MICROSCOPES MARKET, BY END USER
CHAPTER 6: IN-VITRO FERTILIZATION MICROSCOPES MARKET, BY REGION
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report titled, “In-vitro Fertilization Microscopes Market," the in-vitro fertilization microscopes market was valued at $105.40 million in 2021, and is estimated to reach $250.4 million by 2031, growing at a CAGR of 9.4% from 2022 to 2031.IVF procedures such as in-vitro fertilization, semen analysis, general embryo analysis, and oocyte preparation, all employ IVF microscopes. Product development improves therapy effectiveness and is expected to reduce procedure costs. The two most important market developments are high contrast microscopic examinations and improvements in IVF microscope-related equipment.
IVF is a complicated collection of techniques meant to increase fertility, avoid genetic issues, and facilitate childbirth. IVF involves removing mature eggs from the ovaries and fertilizing them with sperm in a lab. For a number of operations, such as sperm analysis, oocyte preparation, in-vitro fertilization, and general embryo analysis, in-vitro fertilization microscopes are employed. Growth in the market is anticipated to be fueled by the rising success rate of in-vitro fertilization treatments and the accessibility of financial aid.
Growth in awareness of IVF therapy, as well as private investments in fertility clinics, are two major factors driving the in-vitro fertilization microscope market growth. IVF clinics provide a variety of services, including the identification of healthy oocytes, the analysis of sperm, the performance of ICSI, the monitoring of embryos, and the freezing & storage of embryos. IVF clinics are increasingly inventing goods for use in IVF clinics and attracting private investors' funding. Mojo, a fertility tech company, received approximately $1.6 million in funding in November 2019. The company is working on a solution that combines AI software and microscopy equipment to help with sperm sampling by focusing on speed, sperm count, and morphology.
Growing government initiatives to increase public awareness of infertility and its treatments, a declining total fertility rate, an increase in IVF clinics, a high success rate for in vitro fertilization, booming fertility tourism, and increased penetration of assisted reproductive technology (ART) across developing regions are all factors driving market growth. In vitro fertilization has elevated to the status of the most effective method for treating infertility due to its increased success rate. It is being used more frequently by childless or infertile couples to conceive children. A donor or non-donor egg is fertilized in a lab with either the partner's sperm or donor sperm using this modern ART technology. This element accelerates the market expansion for in-vitro fertilization microscopes.
The high cost of IVF microscope, lack of reimbursement policies, and the cost of IVF treatment are expected to impede the market growth. As a result, the astronomical cost of assisted reproductive techniques, as well as the lack of insurance coverage for the treatment limit the growth of the in vitro fertilization microscope market.
R&D investment and technological advancement are anticipated to create lucrative opportunities for the market players during the forecast period. The Dynamic Targeting System (DTS), which is compatible with the company's inverted microscopes used for IVF, was introduced by Hamilton Thorne Ltd. in May 2019. In-vitro fertilization technology for microscopes and related instruments has advanced significantly. AI, sperm selection, and embryo screening are only a few of the applications being investigated. Time-lapse technology is employed inside the incubation system to monitor embryos, allowing for non-invasive microscopic imaging of the embryo at specified time intervals.
The in-vitro fertilization microscope market is segmented on the basis of type, end user, and region. On the basis of type, the market is classified into upright microscope, inverted microscope, stereo microscope, and embryo microscope. On the basis of end user, it is divided into clinical and academic research. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, United Arab Emirates, South Africa, and rest of LAMEA).
The key players profiled in the study include Linkam Scientific Instruments, Olympus Corporation, Leica Microsystems, Meiji Techno, Zeiss, Euromex Microscopen B.V., Labomed Europe B.V., Nikon Corporation, Narishige Group, Eppendorf AG, and Hamilton Thorne Ltd. The major players in the market are actively engaged in the adoption of various strategies such as product launches and business expansion.
In 2020, Morula IVF Jakarta, a fertility clinic chain, formed alliances with 14 Women and Children Hospitals, dubbed Morula Satellite Clinics. Within the next five years, the company intends to expand its strategic partnership by introducing satellite programs into 300 Morula Satellite Clinics. Furthermore, the company has increased its number of partnerships by signing 60 new ones in 2021.
Key Market Insights
- By type, the embryo microscope segment emerged as the global leader in 2021 and is anticipated to be the fastest growing segment during the forecast period.
- By end user, the clinical segment emerged as the global leader in 2021 and is anticipated to be the fastest growing segment during the forecast period.
- By region, Europe registered the highest market share in 2021 and is projected to maintain its position during the forecast period.
Companies Mentioned
- LINKAM SCIENTIFIC INSTRUMENTS
- Olympus Corporation
- Leica Microsystems
- Meiji Techno.
- ZEISS International
- Euromex Microscopen B.V.
- Labomed Europe B.V.
- Nikon Corporation
- NARISHIGE Group.
- hamilton thorne, inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Related Reports
From
From
From
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
